Twice-Monthly GLP-1 Shot Helps Manage Blood Sugar, Weight Loss in Trial
A new biweekly GLP-1 injection has been shown to significantly reduce blood sugar in a clinical trial. Image Credit: Hannes P Albert/picture alliance via Getty Images A new GLP-1 medication…
Read the full articleYou might also wanna read

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
First and only GLP-1 pill on the market costs significantly less than injectable versions

Here's how many Americans say they are now taking GLP-1 drugs
As GLP-1 drugs become more widely available, they are reshaping how Americans approach weight management and chronic disease prevention. The

Novo Nordisk’s Wegovy pill approved across the EU
Novo Nordisk’s Wegovy pill has received European Commission approval, becoming the first oral GLP-1 treatment authorised for weight manageme
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
Single DNA injection shows long-lasting weight loss and glucose control in mouse study
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight
New weight loss pill beats oral Ozempic in major trial
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semagl

Comments
Sign in to join the conversation.
No comments yet. Be the first.